90732The CPT code for PNEUMOVAX 23 is 90732. This CPT code is effective as of January 2017 as set forth in the Current Procedural Terminology 2017.
Pneumovax 23 (Pneumovax 23 coupons | What is Pneumovax 23?) is also known as pneumococcal vaccine polyvalent injection (or PPSV23 vaccine)—it protects against 23 types of pneumococcal bacteria. Pneumovax 23 can either be injected IM or SQ (subcutaneously, or under the skin).
The ICD-9-CM diagnosis codes pneumonia vaccine prophylaxis is V03. 82 Pneumococcal prophylaxis. In ICD-10 (scheduled for implementation Oct. 1, 2015), all immunization encounters will have Z23 Encounter for immunization as the primary diagnosis; procedure codes will identify the type(s) of immunizations given.
PPSV23 (Pneumovax or Pnu-Immune) is the most widely available formulation and contains 23 pneumococcal polysaccharides (table 2). In the past, these serotypes caused approximately 85 to 90 percent of cases of pneumococcal disease [1] but now cause only about 50 to 60 percent of such cases in adults [2].
PPSV23 (pneumococcal polysaccharide vaccine) protects against 23 types of pneumococcal bacteria. This vaccine helps prevent invasive infections like meningitis and bacteremia, but only offers low levels of protection against pneumonia.
CDC recommends you: Administer PCV13 before giving any recommended doses of PPSV23. Ensure the child receives 2 doses of PPSV23. The first dose of PPSV23 should be given at least 8 weeks after any prior PCV13 dose, then the second dose of PPSV23 should be given at least 5 years after the first dose of PPSV23.
ICD-10-CM Code for Encounter for immunization Z23.
Other specified counselingICD-10 code Z71. 89 for Other specified counseling is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
G0008 administration of influenza virus vaccine. G0009 administration of pneumococcal vaccine.
Pneumovax 23 is another pneumococcal vaccine. It's more commonly used in adults than children, but it can be used in people as young as 2 years old. Because of the way the vaccine works, it isn't effective for infants and children under 2 years old.
ACIP now recommends that patients have a conversation with their doctor to decide whether to get Prevnar 13. However, older adults who have a high risk for pneumococcal disease should still receive both Prevnar 13 and Pneumovax 23. Additionally, Pneumovax 23 is still recommended for all adults over age 65.
0:351:08Pronunciation of the word(s) "Pneumovax 23". - YouTubeYouTubeStart of suggested clipEnd of suggested clipNew movex 23 new movex 23 new mix twenty.MoreNew movex 23 new movex 23 new mix twenty.